Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B
Hu, Hui‐Han, Jeng, Wen‐Juei, Pan, Mei‐Hung, Luo, Wun‐Sheng, Chang, Chia‐Ling, Huang, Yen‐Tsung, Su, Chien‐Yu, Chiang, Chen‐Tse, Jen, Chin‐Lan, Chien, Yu‐Chuan, Lu, Shen‐Nan, Wang, Li‐Yu, Huang, Li‐Rung, Lee, Mei‐Hsuan, Liu, Jessica, Nguyen, Mindie H., Chen, Chien‐Jen, Yang, Hwai‐I
Published in Alimentary pharmacology & therapeutics (01.03.2022)
Published in Alimentary pharmacology & therapeutics (01.03.2022)
Get full text
Journal Article
The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B
Hu, Hui-Han, Liu, Jessica, Lin, Yu-Ling, Luo, Wun-Sheng, Chu, Yu-Ju, Chang, Chia-Lin, Jen, Chin-Lan, Lee, Mei-Hsuan, Lu, Sheng-Nan, Wang, Li-Yu, You, San-Lin, Yang, Hwai-I, Chen, Chien-Jen
Published in Gut (01.09.2016)
Published in Gut (01.09.2016)
Get full text
Journal Article
Serum soluble program cell death-1 is predictive of hepatocellular carcinoma in untreated chronic hepatitis B patients
Jeng, Rachel Wen-Juei, Chu, Yu-Ju, Pan, Mei-Hung, Hu, Hui-Han, Luo, Wun-Sheng, Su, Chien-Yu, Chiang, Chen-Tse, Jen, Chin-Lan, Lu, Sheng-Nan, Wang, Li-Yu, Chen, Chien-Jen, Yang, Hwai-I
Published in Journal of hepatology (01.07.2022)
Published in Journal of hepatology (01.07.2022)
Get full text
Journal Article